menu search

Context Therapeutics to Participate in Two August 2023 Investor Conferences

Context Therapeutics to Participate in Two August 2023 Investor Conferences
PHILADELPHIA, Aug. 01, 2023 (GLOBE NEWSWIRE) — Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a biopharmaceutical company dedicated to improving the lives of patients living with cancer, today announced that Chief Executive Officer Martin Lehr will participate virtually in two investor conferences in August 2023. Details of the events are as follows: BTIG […] The post Context Therapeutics to Participate in Two August 2023 Investor Conferences appeared first on ForexTV... Read More
Posted: Aug 1 2023, 11:30
Author Name: forextv
Views: 101977

Search within

Pages Search Results: